EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons

Nikhil Singh, Karin Thursky, Gabriela Maron, Joshua Wolf iD

Transplant Infectious Disease · 2023

DOI: 10.1111/tid.14152 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Nikhil Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia. Hauptthemen laut MEDLINE: Neutropenia, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 113 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The use of fluoroquinolones to prevent infections in neutropenic patients with cancer or undergoing hematopoietic stem cell transplantation (HSCT) is a controversial issue, with international guidelines providing conflicting recommendations. Although potential benefits are clear, concerns revolve around efficacy, potential harms, and antimicrobial resistance (AMR) implications.

Discussion

Fluoroquinolone prophylaxis reduces neutropenic fever (NF) bloodstream infections and other serious bacterial infections, based on evidence from systematic reviews, randomized controlled trials, and observational studies in adults and children. Fluoroquinolone prophylaxis may also reduce infection‐related morbidity and healthcare costs; however, evidence is conflicting. Adverse effects of fluoroquinolones are well recognized in the general population; however, studies in the cancer cohort where it is used for a defined period of neutropenia have not reflected this. The largest concern for routine use of fluoroquinolone prophylaxis remains AMR, as many, but not all, observational studies have found that fluoroquinolone prophylaxis might increase the risk of AMR, and some studies have suggested negative impacts on patient outcomes as a result.

Conclusions

The debate surrounding fluoroquinolone prophylaxis calls for individualized risk assessment based on patient characteristics and local AMR patterns, and prophylaxis should be restricted to patients at the highest risk of serious infection during the highest risk periods to ensure that the risk‐benefit analysis is in favor of individual and community benefit. More research is needed to address important unanswered questions about fluoroquinolone prophylaxis in neutropenic patients with cancer or receiving HSCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutropeniaNeoplasmsAdultChildHumansFluoroquinolonesAnti-Bacterial AgentsAntibiotic Prophylaxis

Stichwörter der Autor:innen

antimicrobial stewardshipantimicrobialsbone marrow transplantationfebrile neutropeniafluoroquinolonehematologylevofloxacinneutropenic feveroncologyprophylaxis

Substanzen

FluoroquinolonesAnti-Bacterial Agents

Autor:innen und Institutionen

  • National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • Department of Infectious Diseases, Melbourne Medical School, University of Melbourne, Melbourne, Australia.
  • National Centre for Antimicrobial Stewardship, Department of Infectious Diseases, University of Melbourne, Melbourne, Australia.

ORCID-Profile: Joshua Wolf

Zitieren

APA

Singh, N., Thursky, K., Maron, G., & Wolf, J. (2023). Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons. Transplant Infectious Disease. https://doi.org/10.1111/tid.14152

Vancouver

Singh N, Thursky K, Maron G, Wolf J. Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons. Transplant Infectious Disease. 2023. doi:10.1111/tid.14152

BibTeX
@article{Singh2023,
  author = {Singh, Nikhil and Thursky, Karin and Maron, Gabriela and Wolf, Joshua},
  title = {Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons},
  journal = {Transplant Infectious Disease},
  year = {2023},
  doi = {10.1111/tid.14152}
}
Kostenlos starten →